Which of the following is the preferred antiarrhythmic agent in a patient with cardiac arrest:
**Core Concept**
In cardiac arrest, antiarrhythmic agents are used to stabilize the heart rhythm and restore effective circulation. Amiodarone is a Class III antiarrhythmic agent that works by blocking potassium channels, prolonging the action potential duration, and stabilizing the cardiac membrane.
**Why the Correct Answer is Right**
Amiodarone is the preferred antiarrhythmic agent in cardiac arrest due to its efficacy in treating a wide range of arrhythmias, including ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT). Its mechanism of action involves blocking the potassium channels, which leads to a decrease in the inward potassium current and an increase in the action potential duration. This helps to stabilize the cardiac membrane and restore a normal heart rhythm. Amiodarone also has a favorable safety profile, with minimal proarrhythmic effects.
**Why Each Wrong Option is Incorrect**
**Option B:** Lidocaine is a Class Ib antiarrhythmic agent that is often used to treat ventricular arrhythmias, but it is not the preferred agent in cardiac arrest. Lidocaine can actually worsen VF in some cases.
**Option C:** Procainamide is a Class Ia antiarrhythmic agent that can be used to treat supraventricular arrhythmias, but it is not effective in treating ventricular arrhythmias in cardiac arrest.
**Option D:** Atropine is an anticholinergic agent that is used to treat bradycardia, but it is not an antiarrhythmic agent and is not effective in treating ventricular arrhythmias in cardiac arrest.
**Clinical Pearl / High-Yield Fact**
Amiodarone is often referred to as the "drug of choice" in cardiac arrest due to its efficacy and safety profile. However, it is essential to note that amiodarone should be administered via a central line, as peripheral administration can cause severe hypotension.
**✓ Correct Answer: A. Amiodarone**